<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05619965</url>
  </required_header>
  <id_info>
    <org_study_id>35636/8/22</org_study_id>
    <nct_id>NCT05619965</nct_id>
  </id_info>
  <brief_title>Awake Endotracheal Intubation in Cervical Injury</brief_title>
  <official_title>Awake Endotracheal Intubation With Glidescope Video Assisted Laryngoscope vs Fiberoptic Bronchoscope in Patients With Traumatic Cervical Injury; Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researcher will compare awake endotracheal intubation with glidescope video assisted&#xD;
      laryngoscope vs fiberoptic bronchoscope in patients with traumatic cervical injury;&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred patients undergoing post traumatic cervical spine fixation under general&#xD;
      anesthesia will be randomly allocated to two groups in a prospective study. Between December&#xD;
      2022 and May 2023.&#xD;
&#xD;
      All patients will be premedicated before the procedure and after giving 500 ml of lactated&#xD;
      ringer solution with glycopyrrolate 0.2 mg iv and dexmedetomidine 1 mic/kg IV over 10 minutes&#xD;
      then 0.4 mic/kg/h continuous IV infusion. All patients will receive standard clinical care&#xD;
      monitoring including three lead ECG, noninvasive arterial blood pressure measurement and&#xD;
      pulse oximeter. Patient will be administered oxygen 6 L/min through nasal prong.&#xD;
&#xD;
      Patients will be allocated into two equal groups (50 patients per group) for awake intubation&#xD;
      with either FOB (F group) or GVL (G group) according to computer generated randomization&#xD;
      technique. Each patient will receive nebulization with 5 ml of lidocaine 1% for 5 min&#xD;
      followed by topicalization of soft palate and fauces with 5 puffs of lidocaine spray (10&#xD;
      mg/spray) immediately before the technique of endotracheal intubation (ID 6.5 mm for female&#xD;
      and 7 mm in male, armored tube. Before airway manipulation each patient will receive a bolus&#xD;
      dose of fentanil 1 mic/kg.&#xD;
&#xD;
      During the procedure Philadelphia cervical collar will be removed and MILS of cervical spine&#xD;
      will be carried out by trained assistant (senior registrar anesthetist, 5 years' experience).&#xD;
      After successful intubation (by consultant anesthesia who had more than 100 times successful&#xD;
      intubation with either FOB or GVL) and neurological assessment (by spinal surgeon), general&#xD;
      anesthesia will be induced with propofol 1.5 mg/kg, cisatracurium 0.1 mg/kg and remifentanil&#xD;
      0.5 lg/kg. Hypotension (decreased in MAPP 20% of base line) will be treated with ephedrine&#xD;
      bolus 5-10 mg and 250 ml of lactated ringer solution. Only three attempts will be permitted&#xD;
      per each patient and if failed plan B was to carry out endotracheal intubation under&#xD;
      inhalational induction with FOB without neuromuscular blockade and to exclude patients from&#xD;
      the study. Attempt will be held if O2 saturation decreased below 90%.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2022</start_date>
  <completion_date type="Anticipated">April 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The investigators will compare awake endotracheal intubation with glidescope video assisted laryngoscope vs fiberoptic bronchoscope in patients with traumatic cervical injury</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intubating time</measure>
    <time_frame>immediately post endotracheal intubation</time_frame>
    <description>(defined as the time from introduction of the scope till confirmation of correct endotracheal tube placement with three waves endtidal capnography)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>intubating attempts</measure>
    <time_frame>immediately post endotracheal intubation</time_frame>
    <description>intubating attempts per each patient (will be recorded by dedicated technician).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>immediately post endotracheal intubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>immediately post endotracheal intubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction (score; excellent =1, good =2 and fair = 3).</measure>
    <time_frame>immediately post endotracheal intubation</time_frame>
    <description>(score; excellent =1, good =2 and fair = 3).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Trauma</condition>
  <condition>Patient Satisfaction</condition>
  <condition>Airway Morbidity</condition>
  <arm_group>
    <arm_group_label>Awake Glidoscope Videolaryngoscope</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Awake endotracheal intubation of cervical trauma patients by Glidoscope Videolaryngoscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Awake Fiberoptic bronchoscope</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Awake endotracheal intubation of cervical trauma patients by Fiberoptic bronchoscope</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sedative</intervention_name>
    <description>dexmedetomidine 1 mic/kg IV over 10 minutes then 0.4 mic/kg/h continuous IV infusion</description>
    <arm_group_label>Awake Fiberoptic bronchoscope</arm_group_label>
    <arm_group_label>Awake Glidoscope Videolaryngoscope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Awake endotracheal intubation by Glidescope videolaryngoscope</intervention_name>
    <description>Awake endotracheal intubation by Glidescope videolaryngoscope of cervical trauma patient</description>
    <arm_group_label>Awake Glidoscope Videolaryngoscope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Awake endotracheal intubation by Fiberoptic bronchoscope</intervention_name>
    <description>Awake endotracheal intubation by Fiberoptic bronchoscope of cervical trauma patient</description>
    <arm_group_label>Awake Fiberoptic bronchoscope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA I-II patients&#xD;
&#xD;
          -  ages 26-44&#xD;
&#xD;
          -  undergoing a selective cervical spine fixation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  body mass index (BMI) more than 35 kg/m2.&#xD;
&#xD;
          -  Obstructive airway disease&#xD;
&#xD;
          -  cardiovascular disease&#xD;
&#xD;
          -  apparent airway difficulty&#xD;
&#xD;
          -  patient refusal .&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 9, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>November 30, 2022</last_update_submitted>
  <last_update_submitted_qc>November 30, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Mona Mohamed Mogahed</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypnotics and Sedatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

